VIA Pharmaceuticals, Inc. is a biotechnology company, which engages in the development of compounds for the treatment of cardiovascular diseases. It builds a pipeline of small molecule drugs that intervene directly in the chronic inflammation underlying atherosclerosis. The company was founded by Thomas Quertermous, Adeoye Y. Olukotun and Douglass B. Given on June 14, 2004 and is headquartered in San Francisco, CA.